Premature infants Clinical Trials

13 recruitingLast updated: June 20, 2026

There are 13 actively recruiting premature infants clinical trials across 8 countries. Studies span Not Applicable, Phase 2, Phase 3, Phase 4. Top locations include Boston, Massachusetts, United States, Bursa, Turkey (Türkiye), Clayton, Victoria, Australia. Updated daily from ClinicalTrials.gov.


Premature infants Trials at a Glance

13 actively recruiting trials for premature infants are listed on ClinicalTrialsFinder across 6 cities in 8 countries. The largest study group is Not Applicable with 4 trials, with the heaviest enrollment activity in Boston, Bursa, and Clayton. Lead sponsors running premature infants studies include CHRISTUS Health, Centre Hospitalier Universitaire de Saint Etienne, and Boston Children's Hospital.

Browse premature infants trials by phase

Treatments under study

About Premature infants Clinical Trials

Looking for clinical trials for Premature infants? There are currently 10 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Premature infants trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Premature infants clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 113 of 13 trials

Recruiting
Not Applicable

Effects of Intelligent Parent-child Bonding Intervention on the Physical, Psychological and Social Health of Parents of Premature Infants During Hospitalization and Return Home

Parents of Premature InfantsIntelligent InterventionParent-child Connection
National Defense Medical Center, Taiwan360 enrolled1 locationNCT06987227
Recruiting
Phase 4

Calfactant vs Poractant Alfa Using a Less Invasive Technique in Preterm Infants With Respiratory Distress Syndrome

SurfactantRespiratory Distress Syndrome in Premature InfantsRespiratory Distress Syndrome (RDS)
Uludag University234 enrolled5 locationsNCT07350018
Recruiting

NIRS Monitoring in Premature Infants

Premature infantsHydrocephalusHemorrhage+1 more
Boston Children's Hospital70 enrolled3 locationsNCT02601339
Recruiting
Not Applicable

The Effect of Massage on Sleep Quality, Stress, Comfort, and Vital Signs in Preterm Infants

Premature infantsSleep QualityNICU+3 more
Yuzuncu Yil University40 enrolled1 locationNCT07322731
Recruiting
Phase 2

Anakinra Pilot 2 - A Study to Optimise Dose and Route of Administration of Anakinra in Preterm Infants

Very premature infantsPremature infantsInflammation
Monash Medical Centre24 enrolled2 locationsNCT07254000
Recruiting
Not Applicable

Optimization of Saturation Targets And Resuscitation Trial (OptiSTART)

Premature infantsIntraventricular hemorrhageBronchopulmonary Dysplasia+1 more
University of Texas Southwestern Medical Center700 enrolled1 locationNCT05849077
Recruiting

Justifying humidification management options for infants delivered extremely premature- when and why? A randomised controlled trial. (Y HUMIDIFY).

Hyperthermia in extremely premature infantsSkin integrity/ skin injuries in extremely premature infantsHypothermia in extremely premature infants+2 more
Royal Brisbane and Women's Hospital, Metro North Queensland Health378 enrolled1 locationACTRN12625000726459
Recruiting

Infant Crying, a Bioacoustic Prognostic Signal for Neurodevelopment

Premature infantsInfant DevelopmentNewborn; Vitality
Centre Hospitalier Universitaire de Saint Etienne1,100 enrolled1 locationNCT06332521
Recruiting

Comparing clinical effects of incubator HUMidity at Two levels in Extreme Preterms trial

Extremely premature infants
The University of Sydney308 enrolled8 locationsACTRN12624001332516
Recruiting
Not Applicable

Pilot Trial Investigating Every Other Day Dosing of Oral Iron in Premature Infants (IQONic)

Extremely Low Birth WeightPremature infantsVery Low Birth Weight Infant+2 more
CHRISTUS Health100 enrolled1 locationNCT06555315
Recruiting
Phase 2Phase 3

The To2rpido Study: Targeted Oxygenation in the Resuscitation of Premature Infants and their Developmental Outcome

Oxidative stress in premature infantsBronchopulmonary dysplasia in premature infantsResuscitation in premature infants+1 more
The Royal Hospital for Women1,892 enrolled1 locationACTRN12610001059055
Recruiting
Phase 3

The use of probiotics to reduce the incidence of sepsis in premature infants.

Late onset sepsis in very premature infants (<32 weeks)
The Royal Women's Foundation Ltd1,100 enrolled1 locationACTRN12607000144415
Recruiting
Phase 2

Comparison of two methods of continuous positive airway pressure (CPAP) to support successful extubation of infants of birth weights less than or equal to 1500 grams (C2CPAP)

It has been shown that premature infants are successfully extubated using CPAP. This study compares two popular methods of delivering CPAP to determine if one is more successful at supporting extubation in infants less than or equal to 1500 gram infants.
Sunnybrook and Women's College Health Sciences Centre76 enrolled1 locationACTRN12605000400662